Cubist Pharmaceuticals, Inc. (CBST) Tops Q3 EPS by 54c, Sales Beat Expectations
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Basic net (loss) income per common share (in shares): 75.83M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic net (loss) income per common share (in shares): 75.83M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q3 EPS of $0.85, $0.54 better than the analyst estimate of $0.31. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $182.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- York Space Systems, Inc. (YSS) Reports Q2 Loss of $0.31 ; Offers Guidance
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- Audioeye, Inc. (AEYE) Misses Q2 EPS by 28c; Offer Guidance
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
